Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cenexi
Osny, Ile de France, Francecenexi.com ↗
- Ownership
- Private
- Employees
- ~1500
- Development stage
- Other
01
Overview
Cenexi is an established European CDMO specializing in sterile and injectable pharmaceutical products. The company provides formulation development through to commercial-scale manufacturing for both innovative biotechs and large pharma companies. It has strong expertise in high-potency compounds including cytotoxics, hormones, monoclonal antibodies, antibody-drug conjugates and peptides. Most of its business is focused on sterile injectables (70%+ of turnover), with capabilities spanning clinical trial material production to full commercial supply.
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugatePeptidesBiologic
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Cenexi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cenexi.